First, Tregs promoted CD8+ T cell exhaustion in the tumor by being the main consumer of IL-2; restoration of IL-2 levels locally by blocking gp96/LFA-1–dependent tumor infiltration of Treg was able to reverse CD8+ T cell exhaustion. The gene discussed is ITGB2; the disease is neoplasm.